1.Immunoregulation effects of Tiaomian No. 3 for recurrent spontaneous abortion caused by shortage of blocking antibodies.
Han-Yi GAO ; En-Xue TAO ; Yan WANG
Chinese Journal of Integrated Traditional and Western Medicine 2012;32(6):766-769
OBJECTIVETo study the immunoregulation effects of Tiaomian No. 3 (TM3) for recurrent spontaneous abortion (RSA) caused by shortage of blocking antibodies.
METHODSTotally 61 patients with RSA caused by shortage of blocking antibodies were randomly assigned to the treatment group (31 cases) and the control group (30 cases) by lot method. Patients in the treatment group were treated with TM3, while those in the control group were treated with active immunotherapy using lymphocytes of their spouses. The therapeutic course for all was 3 months. Another 10 healthy females in the same age ranges were recruited as the healthy control group. The blocking antibodies (Ab1), anti-idiotypic antibodies (Ab2), T-lymphocyte cell subsets (CD4 and CD8), serum interleukin 10 (IL-10), and macrophage colony-stimulating factor (M-CSF) levels were determined before and after treatment.
RESULTS(1) After treatment the positive conversion rate of Ab1 and/or Ab2 was 87.1% (27/31) in the treatment group and 86.7% (26/30) in the control group, showing no statistical difference (P > 0.05). (2) In the two groups, CD4 decreased and CD8 increased. The CD4/CD8 ratio was in the normal level after treatment, showing statistical difference when compared with before treatment (P < 0.05). (3) In the two groups, IL-10 and M-CSF levels were higher after treatment, showing statistical difference when compared with before treatment (P < 0.05). (4) The 1-year conception rate was 58.1% (18/31) in the treatment group, significantly higher than that in the control group (46.7%, 14/30, P < 0.05).
CONCLUSIONSTM3 could promote the positive conversion rate of Ab1, promote the production of IL-10 and M-CSF cytokines, thus strengthening the protection for fetus by the mother and the normal maintenance for pregnancy. The 1-year successful pregnancy rate obviously increased in the treatment group.
Abortion, Habitual ; drug therapy ; immunology ; Adult ; Antibodies, Anti-Idiotypic ; Antibodies, Blocking ; CD4-CD8 Ratio ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Female ; Humans ; Immunotherapy, Active ; Interleukin-10 ; blood ; Macrophage Colony-Stimulating Factor ; blood ; Phytotherapy ; Pregnancy ; T-Lymphocyte Subsets
2.Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-gamma.
Kyoung Jin LEE ; Hyun A KIM ; Pyeung Hyeun KIM ; Han soo LEE ; Kyung Ran MA ; Jeong Hyun PARK ; Dae Joong KIM ; Jang Hee HAHN
Experimental & Molecular Medicine 2004;36(6):534-544
During chronic inflammatory response, mono- cytes/macrophages produce 92-kDa matrix metalloproteinase-9 (MMP-9), which may contribute to their extravasation, migration and tissue remodeling. Activation of peroxisome proliferator- activated factor receptor-gamma (PPAR-gamma) has been shown to inhibit MMP-9 activity. To evaluate whether ox-LDL, a PPAR-gamma activator, inhibits PMA-induced MMP-9 expression and activity, and if so, whether CD36 and PPAR-gamma are involved in this process, we investigated the effect of ox-LDL on MMP-9 expression and activity in PMA-activated human monocytic cell line U937. PMA-induced MMP-9 expression and activity were suppressed by the treatment with ox-LDL (50 micrigram/ml) or PPAR-gamma activators such as troglitazone (5 micrometer), ciglitazone (5 micrometer), and 15d- PGJ2 (1 micrometer) for 24 h. This ox-LDL or PPAR-gamma activator-mediated inhibition of micrometer P-9 activity was diminished by the pre-treatment of cells with a blocking antibody to CD36, or PGF2a (0.3 micrometer), which is a PPAR-gamma inhibitor, as well as overexpression of a dominant-negative form of CD36. Taken together, these results suggest that ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-gamma.
Antibodies, Blocking/pharmacology
;
Antigens, CD36/immunology/*physiology
;
Cells, Cultured
;
Chromans/pharmacology
;
Gelatinase B/antagonists & inhibitors/genetics/*metabolism
;
Humans
;
Lipoproteins, LDL/pharmacology/*physiology
;
Monocytes/drug effects/*enzymology/metabolism
;
NF-kappa B/antagonists & inhibitors
;
PPAR gamma/*metabolism
;
Prostaglandin D2/*analogs & derivatives/pharmacology
;
RNA, Messenger/analysis/metabolism
;
Research Support, Non-U.S. Gov't
;
Tetradecanoylphorbol Acetate/antagonists & inhibitors/pharmacology
;
Thiazolidinediones/pharmacology
;
Transcription, Genetic/drug effects
3.Inhibitory effects of purified antibody against α-1 repeat (117-137) on Na(+)-Ca(2+) exchange and L-type Ca(2+) currents in rat cardiomyocytes.
Qi-Long FENG ; Dong-Mei WU ; Xiang-Li CUI ; Hua-Chen ZHAO ; Yuan-Yuan LIN ; Lu-Ying ZHAO ; Bo-Wei WU
Acta Physiologica Sinica 2010;62(5):407-414
Considering that α-1 repeat region may be involved in the ion binding and translocation of Na(+)-Ca(2+) exchanger (NCX), it is possible that the antibodies against NCX α-1 repeat may have a crucial action on NCX activity. The aim of the present study is to investigate the effect of antibody against α-1 repeat (117-137), designated as α-1(117-137), on NCX activity. The antibody against the synthesized α-1(117-137) was prepared and affinity-purified. Whole-cell patch clamp technique was used to study the change of Na(+)-Ca(2+) exchange current (I(Na/Ca)) in adult rat cardiomyocytes. To evaluate the functional specificity of this antibody, its effects on L-type Ca(2+) current (I(Ca,L)), voltage-gated Na(+) current (I(Na)) and delayed rectifier K(+) current (I(K)) were also observed. The amino acid sequences of α-1(117-137) in NCX and residues 1 076-1 096 within L-type Ca(2+) channel were compared using EMBOSS Pairwise Alignment Algorithms. The results showed that outward and inward I(Na/Ca) were decreased by the antibody against α-1(117-137) dose-dependently in the concentration range from 10 to 160 nmol/L, with IC(50) values of 18.9 nmol/L and 22.4 nmol/L, respectively. Meanwhile, the antibody also decreased I(Ca,L) in a concentration-dependent manner with IC(50) of 22.7 nmol/L. No obvious effects of the antibody on I(Na) and I(K) were observed. Moreover, comparison of the amino acid sequences showed there was 23.8% sequence similarity between NCX α-1(117-137) and residues 1 076-1 096 within L-type Ca(2+) channel. These results suggest that antibody against α-1(117-137) is a blocking antibody to NCX and can also decrease I(Ca,L) in a concentration-dependent manner, while it does not have obvious effects on I(Na) and I(K).
Amino Acid Sequence
;
Animals
;
Antibodies, Blocking
;
metabolism
;
pharmacology
;
Calcium Channel Blockers
;
pharmacology
;
Calcium Channels, L-Type
;
genetics
;
immunology
;
metabolism
;
Guinea Pigs
;
Membrane Potentials
;
Molecular Sequence Data
;
Myocytes, Cardiac
;
drug effects
;
metabolism
;
physiology
;
Patch-Clamp Techniques
;
Rats
;
Rats, Wistar
;
Sodium-Calcium Exchanger
;
antagonists & inhibitors
;
genetics
;
immunology
4.Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Eun Young KIM ; Eun Na LEE ; Jienny LEE ; Hae Jung PARK ; Chi Young CHANG ; Da Yeon JUNG ; Su Young CHOI ; Suk Koo LEE ; Jae Won JOH ; Sung Joo KIM
Experimental & Molecular Medicine 2006;38(3):284-294
Blockade of signal 1 or 2 for T-cell activation by the use of anti-CD45RB and anti-CD154 monoclonal antibodies (mAb) (two-signal blockade) has been proven effective in preventing or delaying graft rejection. However, the mechanisms of its immunomodulatory effects are clearly unknown and the present studies were performed to determine how the two-signal blockade modulate allogeneic immune responses, especially T-cell mediated cellular immunity, in a murine skin allograft model. We now report on the profound inhibition of alloreactive T cells by two-signal blockade via CD4-dependent mechanisms. C57BL/6 mice of BALB/c skin allograft were treated with anti-CD45RB, anti-CD154, CTLA4-Ig, or their combinations. For depletion of CD4 or CD8 T cells, the recipients received CD4-depleting or CD8-depleting mAb. We confirmed that survival of skin allograft was markedly prolongated in the two-signal blockade-treated group. In depletion study, anti-CD45RB, anti-CD154 and CD4-depleting mAb-treated group showed acute rejection of skin allograft in contrast to CD8-depleting group treated with the two-signal blockade. In the group treated with the two-signal blockade, the proportions of CD4+CD45RB(low)and CD8+CTLA-4 regulatory T cells were increased while effector CD8+ T cells, including IFN-gamma-secreting and CD8+CD62L(low)T cells, were decreased when compared with non-treated group. In contrast, the CD4-depleted group treated with the two-signal blockade resulted in recovery from immunoregulatory effects of two-signal blockade. In addition, results of IL-4 and IL-10 production were also showed CD4-dependence. Therefore, the two-signal blockade is accompanied by CD4-dependent mechanisms in allogeneic skin transplantation.
Transplantation, Homologous
;
T-Lymphocytes, Regulatory/cytology/immunology
;
Skin Transplantation/*immunology
;
Signal Transduction/drug effects/immunology
;
Mice, Inbred C57BL
;
Mice, Inbred BALB C
;
Mice
;
Male
;
Lymphocyte Depletion
;
Lymphocyte Activation/immunology
;
Interleukin-4/biosynthesis
;
Interleukin-10/biosynthesis
;
Graft Rejection/*immunology/prevention & control
;
Flow Cytometry
;
Cytotoxicity, Immunologic/immunology
;
CD8-Positive T-Lymphocytes/cytology/immunology/metabolism
;
CD40 Ligand/*immunology
;
CD4-Positive T-Lymphocytes/cytology/immunology/metabolism
;
Antigens, CD45/*immunology
;
Antigens, CD4/*immunology
;
Antibodies, Monoclonal/administration & dosage/*pharmacology
;
Antibodies, Blocking/administration & dosage/pharmacology
;
Animals
5.Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin.
Sun Woo PARK ; Jong Sup BAE ; Ki San KIM ; Sun Hee PARK ; Byung Heon LEE ; Je Yong CHOI ; Jae Yong PARK ; Sung Woo HA ; Yong Lim KIM ; Tae Hwan KWON ; In San KIM ; Rang Woon PARK
Experimental & Molecular Medicine 2004;36(3):211-219
Betaig-h3 (betaig-h3) is a secretory protein composed of fasciclin I-like repeats containing sequences that allows binding of integrins and glycosaminoglycans in vivo. Expression of betaig-h3 is responsive to TGF-beta and the protein is found to be associated with extracellular matrix (ECM) molecules, implicating betaig-h3 as an ECM adhesive protein of developmental processes. We previously observed predominant expression of betaig-h3 expression in the basement membrane of proximal tubules of kidney. In this study, the physiological relevance of such localized expression of betaig-h3 was examined in the renal proximal tubular epithelial cells (RPTEC). RPTEC constitutively expressed betaig-h3 and the expression was dramatically induced by exogenous TGF-beta1 treatment. betaig-h3 and its second and fourth FAS1 domain were able to mediate RPTEC adhesion, spreading and migration. Two known alpha3beta1 integrin-interaction motifs including aspartatic acid and isoleucine residues, NKDIL and EPDIM in betaig-h3 were responsible to mediate RPTEC adhesion, spreading, and migration. By using specific antibodies against integrins, we confirmed that alpha3beta1 integrin mediates the adhesion and migration of RPTECs on betaig-h3. In addition, it also enhanced proliferation of RPTECs through NKDIL and EPDIM. These results indicate that betaig-h3 mediates adhesion, spreading, migration and proliferation of RPTECs through the interaction with alpha3beta1 integrin and is intimately involved in the maintenance and the regeneration of renal proximal tubular epithelium.
Amino Acid Motifs
;
Antibodies, Blocking/immunology
;
Cell Adhesion/physiology
;
Cell Movement/physiology
;
Cell Proliferation
;
Cells, Cultured
;
Epithelial Cells/drug effects
;
Extracellular Matrix Proteins/chemistry/immunology/*metabolism
;
Humans
;
Integrin alpha3beta1/chemistry/immunology/*metabolism
;
Kidney Tubules, Proximal/cytology/metabolism/*physiology
;
Peptides/chemistry/metabolism
;
Protein Interaction Mapping
;
Research Support, Non-U.S. Gov't
;
Transforming Growth Factor beta/chemistry/immunology/*metabolism/pharmacology